Novartis

Novartis

Web: Novartis external link
Lieu: Bâle
Domaine: Médecine/Pharmacologie
Lié à:

Research & Development at Novartis The Novartis Pharmaceuticals clinical pipeline holds a broad stream of 140 future projects including both new molecular entities and additional indications or formulations for marketed products. Our pipeline has consistently being ranked by experts as one of the strongest in the industry. Our scientists focus on diseases for which medical need remains unmet and strive to improve the drug discovery process with an approach that integrates novel concepts and tools across multiple disease areas.
#display_name

- NOVARTIS
Médecine 27.4
Positive top-line results seen with Arzerra plus fludarabine and cyclophosphamide in chronic lymphocytic leukemia (CLL) patients when initial treatment stopped working - CLL is the most commonly diagnosed adult leukemia in Western countries, accounting for approximately 1 in 4 cases of all leukemia , - Most CLL patients experience disease progression despite initial response to
Économie 23.4

Continuing operations saw sales, core operating income and core EPS grow (cc ) in Q1 - Net sales were USD 11.9 billion (-7%, +3% cc) - Operating income was USD 2.8 billion (-1%, +15% cc) - Core operating income (-4%, +9% cc) grew faster than sales (cc), resulting in core margin of 30.6

Médecine 21.4

New FREEDOMS/FREEDOMS II sub-group analysis showed Gilenya-treated patients were six-times more likely to achieve 'no evidence of disease activity (NEDA4)' vs placebo - NEDA4 is based on four key measures of relapsing MS (RMS): relapses, MRI lesions, MS-related brain shrinkage and di

Médecine 16.4

US Food and Drug Administration (FDA) grants approval of the AcrySof IQ ReSTOR +2.5 Diopter (D) Intraocular Lens (IOL) for sale in the US - Expands Alcon's IOL portfolio for the correction of near, intermediate and distance vision in patients undergoing cataract surgery, with

Médecine 21.4

More than 27,000 Novartis associates worldwide dedicate an estimated 200,000 hours to volunteer with charitable causes in their communities - Community Partnership Day symbolizes the company's commitment to improving health and serving its local communities - Associates are partic

Médecine 16.4

Glatopa is the first FDA-approved, substitutable generic version of Copaxone 20mg, a treatment for relapsing forms of multiple sclerosis - Novartis and Sandoz are driving access to a full range of differentiated, high-quality MS therapeutic options, complemented by a full range of s

Médecine 15.4

Significant improvement in PFS seen with Arzerra plus chlorambucil in previously untreated patients with CLL for whom fludarabine-based therapy was inappropriate - Chronic lymphocytic leukemia (CLL) is the most commonly diagnosed adult leukemia in Western countries, accounting for approxi



website preview

Link

Medicine and Life Sciences
Logo Careerjet